Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Bone Marrow Transplant ; 27(10): 1071-3, 2001 May.
Article in English | MEDLINE | ID: mdl-11438823

ABSTRACT

Respiratory syncytial virus (RSV) infection is an important cause of respiratory mortality in immunosuppressed patients, including bone marrow transplant (BMT) recipients. The presence of lower respiratory tract infection and infection in the pre-engraftment phase of BMT is believed to confer a poor prognosis. Three patients who underwent allogeneic BMT at our institution developed RSV pneumonia over 1 year post BMT, with the underlying disease in remission. All three were hypoxic with extensive pulmonary disease at presentation. Treatment consisted of aerosolized ribavirin and intravenous immune globulin with successful clearing of viral shedding and excellent clinical outcomes. RSV infection is probably less severe in the late post-BMT period, but needs to be considered early in the differential diagnosis of pulmonary infiltrates in this patient population.


Subject(s)
Bone Marrow Transplantation/adverse effects , Respiratory Syncytial Virus Infections/etiology , Adult , Disease-Free Survival , Female , Humans , Immunoglobulins, Intravenous/administration & dosage , Male , Respiratory Syncytial Virus Infections/drug therapy , Ribavirin/administration & dosage , Time Factors , Transplantation, Homologous/adverse effects
SELECTION OF CITATIONS
SEARCH DETAIL
...